Ee Wee - Haw Par CEO

All Insiders . USA . 
Stock . Haw Par . Stakeholders . Insider . Ee Wee
HAWPY Stock  USD 28.64  0.00  0.00%   

CEO

Mr. Wee Ee Lim is President, Chief Executive Officer, Executive Director of Haw Par Corporation Ltd. He joined the Group in 1986 and became President CEO of Haw Par Corporation Limited in 2003. He was appointed to the Board on 23 March 1994 and was last reelected on 28 April 2015. Mr Wee is a member of the Investment Committee. He was closely involved in the management and growth of the Group over the last 30 years. He is a Director and Deputy Chairman of UOL Group Limited. He is a Director of United Industrial Corporation Limited and Wee Foundation. He was previously a Director of Pan Pacific Hotels Group Limited, Singapore Land Limited and Hua Han Health Industry Holdings Limited . He holds a Bachelor of Arts degree from Clark University, USA. since 2003.
Age 62
Tenure 21 years
Phone65 6337 9102
Webhttps://www.hawpar.com

Haw Par Management Efficiency

Haw Par's management efficiency ratios could be used to measure how well Haw Par manages its routine affairs as well as how well it operates its assets and liabilities.
Haw Par has accumulated 762 K in total debt. Haw Par has a current ratio of 8.84, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Haw Par until it has trouble settling it off, either with new capital or with free cash flow. So, Haw Par's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Haw Par sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Haw to invest in growth at high rates of return. When we think about Haw Par's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CEO Age

Brian McNamaraGlaxoSmithKline PLC ADR
49
William AndersonRoche Holding Ltd
57
Emma WalmsleyGlaxoSmithKline PLC ADR
55
Deborah WaterhouseGlaxoSmithKline PLC ADR
N/A
Pascal SoriotAstraZeneca PLC ADR
60
Jacob NaardenEli Lilly and
39
Severin SchwanRoche Holding Ltd
56
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company was incorporated in 1969 and is based in Singapore. Haw Par operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. Haw Par [HAWPY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Equity0.0424
Return On Asset0.0063

Haw Par Leadership Team

Elected by the shareholders, the Haw Par's board of directors comprises two types of representatives: Haw Par inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw Par's management team and ensure that shareholders' interests are well served. Haw Par's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw Par's outside directors are responsible for providing unbiased perspectives on the board's policies.
Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd
Kun Chiew, Group Sec
Say Chow, Group Finance Controller
Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited
Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare
Tang Lee, Mang Communications
Tang Chow, Human Director
Brian Loo, Group Mang

Haw Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw Par a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0424
Return On Asset0.0063
Profit Margin0.79 %
Operating Margin0.19 %
Current Valuation(701.58 M)
Shares Outstanding55.34 M
Price To Earning21.33 X
Price To Book0.73 X
Price To Sales10.01 X
Revenue141.18 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Additional Tools for Haw Pink Sheet Analysis

When running Haw Par's price analysis, check to measure Haw Par's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw Par is operating at the current time. Most of Haw Par's value examination focuses on studying past and present price action to predict the probability of Haw Par's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw Par's price. Additionally, you may evaluate how the addition of Haw Par to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY